CC1(C(=O)NS(=O)(=O)c2ccc(Cl)s2)CCN1C(=O)Cc1ccc(Cl)cc1Cl
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?